ephrin-a5 has been researched along with Local Neoplasm Recurrence in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpén, O; Grénman, S; Gucciardo, E; Hietanen, S; Höpfner, K; Huhtinen, K; Hynninen, J; Jukonen, J; Lehti, K; Lehtinen, L; Moyano-Galceran, L; Ojala, PM; Pietilä, EA | 1 |
1 other study(ies) available for ephrin-a5 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Disease Progression; Ephrin-A5; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Receptor, EphA2; Signal Transduction; Survival Analysis; Up-Regulation | 2021 |